Sana Biotechnology (SANA)
(Delayed Data from NSDQ)
$3.09 USD
-0.20 (-6.08%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $3.11 +0.02 (0.65%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth C Momentum C VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
SANA 3.09 -0.20(-6.08%)
Will SANA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SANA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SANA
SANA Gears Up to Report Q4 Earnings: What's in the Cards?
SANA Stock Surges 152% in a Week on Upbeat Initial Diabetes Study Data
SANA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Sana (SANA) Could be Great Choice for a Bottom Fisher
Down -24.69% in 4 Weeks, Here's Why Sana (SANA) Looks Ripe for a Turnaround
Other News for SANA
Fell Below 20 Day Moving Average appears for SANA after 6.08% move
SANA Crossed Above 20 Day Moving Average on September 18
Is SANA setting up for a drop? 20 Day Moving Average Resistance shows up after slipping 1.94%
H.C. Wainwright Sticks to Their Buy Rating for Sana Biotechnology (SANA)
Is SANA primed for downward momentum? Fell Below 20 Day Moving Average shows up after sinking 4.02%